Acuta Capital Partners
Belmont, Californiaacutacapital.com
Overview
Acuta Capital Partners, LLC provides investment management services to Clients. Acuta's investment philosophy is based on bottom-up analysis, absolute-value oriented investing, and a long-term perspective. Acuta intends to employ a value approach to investing that is risk averse and focused on preserving capital over the long run . Acuta invests in securities of small-cap and mid-cap issuers, which may present greater risks than those of large-cap issuers .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Surrozen | Mar 2025 | Private Placement | - |
| Enliven Therapeutics | Mar 2024 | Private Placement | - |
| ELVN-ELVN | Mar 2024 | PIPE | Co-investor |
| RZLT | May 2022 | Follow-on Offering | Co-investor |
| RayzeBio | Jun 2021 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
